General
impact 16
FDA approval, fundraising, and the reality of building in healthcare according to BioticsAI founder
FDA approval, fundraising, and the reality of building in healthcare according to BioticsAI founder BioticsAI CEO Robhy Bustami joined Isabelle Johannessen on Build Mode to discuss how the company has navigated a highly…
Why it matters
The timing matters: bioticsai is converging with shifts in approval, which could amplify the downstream impact.